HIGHLIGHTS
- who: Laura Kist de Ruijter from the (UNIVERSITY) have published the paper: Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial, in the Journal: (JOURNAL) of 31/03/2022
- how: Similar observations were made for 89Zr-pembrolizumab imaging16.
- future: For future studies the authors envision also an earlier second imaging time point namely within two weeks after starting ICI therapy to capture pharmacodynamic changes before substantial tumor shrinkage.
SUMMARY
Received A list of authors and their affiliations appears at the end of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.